S-1 – Artiva Biotherapeutics, Inc.

S-1

from S-1 288 pages S-1

06/28/24

EX-3.1

from S-1 21 pages Amended and Restated Certificate of Incorporation of Artiva Biotherapeutics, Inc

06/28/24

EX-3.2

from S-1 6 pages Amended and Restated Certificate of Incorporation of Artiva Biotherapeutics, Inc

06/28/24

EX-3.3

from S-1 30 pages Bylaws of Artiva Biotherapeutics, Inc

06/28/24

EX-3.4

from S-1 23 pages Amended and Restated Bylaws of Artiva Biotherapeutics, Inc

06/28/24

EX-4.1

from S-1 2 pages Indenture or similar

06/28/24

EX-4.2

from S-1 57 pages Amended and Restated Investors’ Rights Agreement

06/28/24

EX-10.1

from S-1 13 pages Indemnity Agreement

06/28/24

EX-10.2

from S-1 21 pages Artiva Biotherapeutics, Inc. 2020 Equity Incentive Plan Adopted by the Board of Directors: June 24, 2020 Approved by the Stockholders: June 25, 2020 Amended by the Board of Directors: December 18, 2020 Approved by the Stockholders: December 18, 2020 Amended by the Board of Directors: February 19, 2021 Approved by the Stockholders: February 19, 2021 Amended by the Board of Directors: July 29, 2021 Approved by the Stockholders: August 23, 2021 Amended by the Board of Directors: August 24, 2022 Approved by the Stockholders: August 30, 2022 Termination Date: June 23, 2030

06/28/24

EX-10.3

from S-1 28 pages Artiva Biotherapeutics, Inc. Stock Option Grant Notice

06/28/24

EX-10.4

from S-1 34 pages Artiva Biotherapeutics, Inc. 2024 Equity Incentive Plan Adopted by the Board of Directors: [ ], 2024 Approved by the Stockholders: [ ], 2024

06/28/24

EX-10.5

from S-1 32 pages Artiva Biotherapeutics, Inc. Stock Option Grant Notice

06/28/24

EX-10.6

from S-1 21 pages Artiva Biotherapeutics, Inc. Rsu Award Grant Notice

06/28/24

EX-10.7

from S-1 15 pages Artiva Biotherapeutics, Inc. 2024 Employee Stock Purchase Plan Adopted by the Board of Directors: [ ], 2024 Approved by the Stockholders: [ ], 2024 Ipo Date: [ ], 2024

06/28/24

EX-10.9

from S-1 12 pages Re: Employment Offer Letter Dear Fred,

06/28/24

EX-10.10

from S-1 9 pages Private & Confidential

06/28/24

EX-10.11

from S-1 11 pages Re: Employment Offer Letter Dear Jennifer, on Behalf of Artiva Biotherapeutics, Inc. (The “Company”), I Am Pleased to Offer You Employment Under the Terms Set Forth in This Offer Letter Agreement (This “Agreement”). These Employment Terms Will Be Effective as of Your Start Date, September 16th, 2020

06/28/24

EX-10.12

from S-1 67 pages Office Lease

06/28/24

EX-10.13

from S-1 51 pages Option and License Agreement

06/28/24

EX-10.14

from S-1 2 pages Amendment No. 1 to Option and License Agreement

06/28/24

EX-10.15

from S-1 9 pages Omnibus Amendment

06/28/24

EX-10.16

from S-1 27 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Both (I) Not Material and (II) Is the Type That the Registrant Treats as Private or Confidential. 1. Introduction

06/28/24

EX-10.17

from S-1 1 page Amendment No. 1 to Master Agreement for Manufacturing Services

06/28/24

EX-10.18

from S-1 15 pages Master Research Services Agreement

06/28/24

EX-10.19

from S-1 24 pages Selected Product License Agreement

06/28/24

EX-10.20

from S-1 25 pages Selected Product License Agreement

06/28/24

EX-10.21

from S-1 7 pages Amendment to Selected Product License Agreement

06/28/24

EX-10.22

from S-1 127 pages Lease Agreement

06/28/24

EX-10.23

from S-1 15 pages License Agreement

06/28/24

EX-10.24

from S-1 3 pages First Amendment to License Agreement

06/28/24

EX-10.25

from S-1 26 pages Selected Product License Agreement

06/28/24

EX-10.26

from S-1 65 pages Collaboration Agreement

06/28/24

EX-10.27

from S-1 2 pages First Amendment to Collaboration Agreement

06/28/24

EX-10.28

from S-1 3 pages Amendment No. 2 to Strategic Collaboration Agreement

06/28/24

EX-10.29

from S-1 9 pages Private & Confidential

06/28/24

EX-10.30

from S-1 9 pages Consulting Agreement

06/28/24

EX-10.31

from S-1 2 pages Amendment No. 1 to Consulting Agreement

06/28/24

EX-10.32

from S-1 10 pages 3/28/2023 Michael Faerm Re: Separation Agreement Dear Mike: This Letter Sets Forth the Substance of the Separation Agreement (The “Agreement”) That Artiva Biotherapeutics, Inc. (The “Company”) Is Offering to You to Aid in Your Employment Transition. 1. Separation. Your Employment Termination Date Will Be March 31, 2023 (The “Separation Date”)

06/28/24

EX-10.33

from S-1 12 pages Re: Separation Agreement Dear Pete: This Letter Sets Forth the Substance of the Separation Agreement (The “Agreement”) That Artiva Biotherapeutics, Inc. (The “Company”) Is Offering to You to Aid in Your Employment Transition. 1. Separation. Your Employment Termination Date Will Be March 31, 2023 (The “Separation Date”)

06/28/24

EX-10.34

from S-1 9 pages Consulting Agreement

06/28/24

EX-10.35

from S-1 3 pages Amendment No. 1 to Consulting Agreement

06/28/24

EX-10.36

from S-1 8 pages Re: Employment Offer Letter Dear Neha,

06/28/24

EX-10.37

from S-1 7 pages Re: Employment Offer Letter Dear Heather, on Behalf of Artiva Biotherapeutics, Inc. (The “Company”), I Am Pleased to Offer You Employment Under the Terms Set Forth in This Offer Letter Agreement (This “Agreement”). These Employment Terms Will Be Effective as of Your Start Date, Which Will Be on or Around October 22, 2020 (The “Start Date”)

06/28/24

EX-10.38

from S-1 9 pages Consulting Agreement

06/28/24

EX-23.1

from S-1 1 page Consent of expert or counsel

06/28/24

EX-FILING FEES

from S-1 ~1 page

06/28/24

Exhibits

Graphics & Data Files

External Links